Angiotensin converting enzyme insertion/deletion polymorphism and risk of pregnancy hypertensive disorders: A meta-analysis

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 13, Issue 1, 2012, Pages 184-195

  Chen, Zhen ^a,b   Xu, Fang ^a   Wei, Yonggang ^c   Liu, Fei ^c   Qi, Hongbo ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Chongqing Hospital for Maternal and Children's Care   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Angiotensin converting enzyme; meta analysis; polymorphism; pregnancy hypertensive disorders

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; ASIAN; CAUCASIAN; DNA POLYMORPHISM; ECLAMPSIA AND PREECLAMPSIA; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INDEL MUTATION; MATERNAL HYPERTENSION; META ANALYSIS; OUTCOME ASSESSMENT; RISK FACTOR;

FEMALE; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INDEL MUTATION; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; PUBLICATION BIAS; RISK FACTORS;

EID: 84859965682     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320311427755     Document Type: Article

References (61)

1. Xiong X, Mayes D, Demianczuk N, Olson DM, Davidge ST, Newburn-Cook C, et al. Impact of pregnancy-induced hypertension on fetal growth. Am J Obstet Gynecol 1999; 180: 207-213. (Pubitemid 29088416)
2. Xiong X, Buekens P, Pridjian G and Fraser WD. Pregnancy-induced hypertension and perinatal mortality. J Reprod Med 2007; 52: 402-406. (Pubitemid 46799293)
3. Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 307: 1066-1074.
4. Clark SL, Belfort MA, Dildy GA, et al. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol 2008; 199: 36.e1-36.e5.
5. Berg CJ, Harper MA, Atkinson S, et al. Preventability of pregnancy-related deaths. Obstet Gynecol 2005; 106: 1228-1234.
6. Medica I, Kastrin A and Peterlin B. Genetic polymorphisms in vasoactive genes and preeclampsia: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 2007; 131: 115-126. (Pubitemid 46452915)
7. Serrano NC. Immunology and genetic of preeclampsia. Clin Dev Immunol 2006; 13: 197-201. (Pubitemid 44963422)
8. Nielsen AH, Schauser KH and Puolsen K. Current topic: the uteroplacental renin-angiotensin system. Placenta 2000; 21:468-477. (Pubitemid 30609350)
9. Lachmeijer AM, Dekker GA, Pals G, Aarnoudse JG, ten Kate LP and Arngrimsson R. Searching for preeclampsia genes: the current position. Eur J Obstet Gynecol Reprod Biol 2002; 105: 94-113.
10. Ehlers MR and Riordan JF. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 1989; 28: 5311-5318. (Pubitemid 19175737)
11. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346. (Pubitemid 20370444)
12. Keavney B, McKenzie C, Parish S, et al. Large-scale test of hypothesised associations between the angiotensin-converting enzyme insertion/deletion polymorphism and myocardial infarction in about 5,000 cases and 6,000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet 2000; 355: 434-442. (Pubitemid 30085151)
13. Casas JP, Hingorani AD, Bautista LE and Sharma P. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 2004; 61: 1652-1661. (Pubitemid 39463422)
14. Bonnici F, Keavney B, Collins R and Danesh J. Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studies. BMJ 2002; 325: 517-520.
15. Ng DP, Tai BC, Koh D, Tan KW and Chia KS. Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia 2005; 48: 1008-1016. (Pubitemid 40767996)
16. Serrano NC, Díaz LA, Páez MC, et al. Angiotensin-converting enzyme I/D polymorphism and preeclampsia risk: evidence of small-study bias. PLoS Med 2006; 3: e520.
17. Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10:101-129.
18. Higgins JP, Thompson SG, Deeks JJ and Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-560. (Pubitemid 37088507)
19. Mantel N and Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
20. DerSimonian R and Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188. (Pubitemid 17189972)
21. Begg CB and Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
22. Egger M, Davey Smith G, Schneider M and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634. (Pubitemid 27387172)
23. Kaur R, Jain V, Khuller M, Gupta I and Sherawat BS. Association of angiotensin-converting enzyme gene polymorphism with pregnancy-induced hypertension. Acta Obstet Gynecol Scand 2005; 84: 929-933. (Pubitemid 41400291)
24. Roberts CB, Rom L, Moodley J and Pegoraro RJ. Hypertension-related gene polymorphisms in pre-eclampsia, eclampsia and gestational hyper-tension in Black South African women. J Hypertens 2004; 22: 945-948. (Pubitemid 38680469)
25. Choi H, Kang JY, Yoon HS, et al. Association of Angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia. J Korean Med Sci 2004; 19: 253-257. (Pubitemid 38591800)
26. Gurdol F, Isbilen E, Yilmaz H, Isbir T and Dirican A. The association between preeclampsia and angiotensin-converting enzyme insertion/deletion polymorphism. Clin Chim Acta 2004; 341: 127-131. (Pubitemid 38210323)
27. Galao AO, de Souza LH, da Costa BE, Scheibe RM and de Figueiredo CE. Angiotensin-converting enzyme gene polymorphism in preeclampsia and normal pregnancy. Am J Obstet Gynecol 2004; 191: 821-824. (Pubitemid 39298117)
28. Kim YJ, Park MH, Park HS, et al. Associations of polymorphisms of the angiotensinogen M235 polymorphism and angiotensin-converting-enzyme intron 16 insertion/deletion polymorphism with preeclampsia in Korean women. Eur J Obstet Gynecol Reprod Biol 2004; 116: 48-53. (Pubitemid 39044494)
29. Heiskanen JT, Pirskanen MM, Hiltunen MJ, et al. Insertion-deletion polymorphism in the gene for angiotensin-converting enzyme is associated with obstetric cholestasis but not with preeclampsia. Am J Obstet Gynecol 2001; 185: 600-603. (Pubitemid 32862545)
30. Kobashi G, Hata A, Shido K, et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene and preeclampsia in Japanese patients. Semin Thromb Hemost 2005; 31: 346-350. (Pubitemid 40962397)
31. Morgan L, Foster F, Hayman R, et al. Angiotensin-converting enzyme insertion-deletion polymorphism in normotensive and pre-eclamptic pregnancies. J Hypertens 1999; 17: 765-768. (Pubitemid 29322162)
32. Bouba I, Makrydimas G, Kalaitzidis R, et al. Interaction between the polymorphisms of the renin-angiotensin system in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2003; 110: 8-11. (Pubitemid 37025689)
33. Dizon-Townson D, Lompe I, Hastings S, et al. A common genetic variant of the angiotensin converting enzyme is associated with both preeclampsia and chronic hypertension [abstract]. Am J Obstet Gynecol 1995; 172: 374.
34. Levesque S, Moutquin JM, Lindsay C, Roy MC and Rousseau F. Implication of an AGT haplotype in a multigene association study with pregnancy hypertension. Hypertension 2004; 43: 71-78. (Pubitemid 38031913)
35. Mozgovaia EV, Malysheva OV, Ivashchenko TE and Branov VS. Genetic predisposition to pre-eclampsia: polymorphism of genes involved in regulation of endothelial functions. Balkan J Med Genetics 2002; 5: 19-26. (Pubitemid 37432333)
36. Roh CR, Kim DK, Yoon BK, et al. A common genetic variant of the angiotensin converting enzyme (ACE) gene and pregnancy induced hypertensive disorders. Korean J Obstet Gynecol 1997; 40: 1189-1199.
37. Seremak-Mrozikiewicz A, Drews K, Malewski Z, Slomko Z and Mrozikiewicz A. Polymorphic genotypes of the angiotensin-converting enzyme in severe pregnancy-induced hypertension. Arch Perinat Med 2000; 6: 22-24.
38. Tamura T, Johanning GL, Goldenberg RL, Johnston KE, DuBard MB. Effect of angiotensin-converting enzyme gene polymorphism on pregnancy outcome, enzyme activity, and zinc concentration. Obstet Gynecol 1996; 88: 497-502. (Pubitemid 26326006)
39. Watanabe H, Hamada H, Yamakawa-Kobayashi K, Yoshikawa H and Arinami T. Evidence for an association of the R485K polymorphism in the coagulation factor V gene with severe preeclampsia from screening 35 polymorphisms in 27 candidate genes. Thromb Haemost 2001; 86: 1594-1595. (Pubitemid 34007546)
40. Zhou N, Yu P, Chen J, Huang H and Jiang S. Detection of insertion/deletion polymorphism of angiotensin converting enzyme gene in preeclampsia. Chin J Med Genet 1999; 16: 29-31. (Pubitemid 29090433)
41. Aggarwal PK, Jain V and Jha V. Endothelial nitric oxide synthase, angiotensin-converting enzyme and angiotensinogen gene polymorphisms in hypertensive disorders of pregnancy. Hypertens Res 2010; 33: 473-477.
42. Uma R, Forsyth SJ, Struthers AD, Fraser CG, Godfrey V and Murphy DJ. Polymorphisms of the angiotensin converting enzyme gene in early-onset and late-onset pre-eclampsia. J Matern Fetal Neonatal Med 2010; 23: 874-879.
43. Mandò C, Antonazzo P, Tabano S, et al. Angiotensin-converting enzyme and adducin-1 polymorphisms in women with preeclampsia and gestational hypertension. Reprod Sci 2009; 16: 819-826.
44. Li H, Ma Y, Fu Q and Wang L. Angiotensin-converting enzyme insertion/deletion (ACE I/D) and angiotensin II type 1 receptor (AT1R) gene polymorphism and its association with preeclampsia in Chinese women. Hypertens Pregnancy 2007; 26: 293-301. (Pubitemid 47295350)
45. Velloso EP, Vieira R, Cabral AC, Kalapothakis E and Santos RA. Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I-converting enzyme deletion/deletion genotype. Braz J Med Biol Res 2007; 40: 583-590.
46. Serrano NC, Díaz LA, Páez MC, et al. Angiotensin-converting enzyme I/D polymorphism and preeclampsia risk: evidence of small-study bias. PLoS Med 2006; 3: e520.
47. Mello G, Parretti E, Gensini F, et al. Maternal-fetal flow, negative events, and preeclampsia: role of ACE I/D polymorphism. Hypertension 2003; 41: 932-937. (Pubitemid 36418468)
48. Yan W, Kulane A, Xiang P, Li Z, Di H and Nie S. Maternal and fetal angiotensin-converting enzyme gene insertion/deletion polymorphism not associated with pregnancy-induced hypertension in Chinese women. J Matern Fetal Neonatal Med 2011 Jan 20. [Epub ahead of print].
49. Bai H, Liu X, Liu R, Liu Y, Li M and Liu B. Angiotensinogen and angiotensin-I converting enzyme gene variations in Chinese pregnancy induced hypertension. Hua Xi Yi Ke Da Xue Xue Bao 2002; 33: 233-237.
50. Huang Y, Liao B and Sun X. Study on the relation between the angiotensin converting enzyme gene and pregnancy induced hypertension. Zhonghua Fu Chan Ke Za Zhi 2001; 36: 15-17.
51. Zhu M, Xia Y and Cheng W. Study on a deletion polymorphism of the angiotensin converting enzyme gene in pregnancy induced hypertension. Zhonghua Fu Chan Ke Za Zhi 1998; 33: 83-85.
52. Wang HY, Li CM, Wang Z and Yang F. Relationships between polymorphisms of angiotensin-converting enzyme and methylenetetrahydrofolate reductase genes and genetic susceptibility to pregnancy induced hypertension. Zhonghua Fu Chan Ke Za Zhi 2004; 39: 369-372.
53. Ehlers MRW and Riordan Jr. Angiotensin-converting enzyme. Biochemistry and molecular biology. In: Laragh JH, Brenner BM (eds). Hypertension: pathophysiology, diagnosis, and management. New York: Raven Press, 1990, pp. 1217-1231.
54. Soubrier F, Hubert C, Testut P, Nadaud S, Alhenc-Gelas F and Corvol P. Molecular biology of the angiotensin I converting enzyme: biochemistry and structure of the gene. J Hypertens 1993; 11: 471-476. (Pubitemid 23154336)
55. Erdos EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture. Hypertension 1990; 16: 363-370. (Pubitemid 20338530)
56. Benedetto C, Marozio L, Ciccone G, et al. Synergistic effect of renin-angiotensin system and nitric oxide synthase genes polymorphisms in pre-eclampsia. Acta Obstet Gynecol Scand 2007; 86: 678-682. (Pubitemid 46801781)
57. Amaral LM, Palei AC, Sandrim VC, et al. Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancy. J Hum Hypertens 2011 Jun 30. doi: 10.1038 /jhh. 2011.65. [Epub ahead of print].
58. Mitchell AA, Cutler DJ and Chakravarti A. Undetected genotyping errors cause apparent overtransmission of common alleles in the transmission/ disequilibrium test. Am J Hum Genet 2003; 72: 598-610. (Pubitemid 36255959)
59. Hosking L,Lumsden S, Lewis K, et al. Detection of genotyping errors by Hardy-Weinberg equilibrium testing. Eur J Hum Genet 2004; 12: 395-399. (Pubitemid 38660191)
60. Salanti G, Amountza G, Ntzani EE and Ioannidis JP. Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet 2005; 13: 840-848. (Pubitemid 40946083)
61. Trikalinos TA, Salanti G, Khoury MJ and Ioannidis JP. Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol 2006; 163: 300-309. (Pubitemid 43238423)